Summary.-Diethylnitrosamine (DEN), at a concentration of 100 parts/106 in drinking water for 14 days, caused the development, by 48 weeks, of very few liver tumours in 5 of 18 (27%) male F-344 rats fed control diet. When the DEN treatment was followed one week later by continuous feeding of the hypolipidemic hepatic peroxisome proliferator, Wy-14,643, at 0.10,0 dietary level, all of 28 rats (1000o) developed, between 38 and 48 weeks, a significantly higher number of liver tumours. Furthermore, laparotomy at 22 weeks revealed that several rats fed Wy-14,643 after DEN initiation had developed visible liver nodules, suggesting that Wy-14,643 also accelerates the appearance of these tumours. Administration of another peroxisome proliferator, clofibrate, at 0.5o,' level in the diet after DEN initiation, also caused a substantial enhancement of liver tumorigenesis. The enhancement of liver-tumour development by clofibrate, however, was less than that by Wy-14,643. The marked enhancing effect of Wy-14,643 may be due to its profound hepatomegalic and peroxisome proliferative properties.
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CHEMICAL carcinogens, even when administered at a subcarcinogenic level, produce an irreversible neoplastic change in some cells of the target organ which is referred to as "initiation". Subsequent exposure to certain non-carcinogenic or weakly carcinogenic agents leads to accelerated development of tumours, a process referred to as "promotion" (Boutwell, 1974; Frei, 1976) . This concept of initiation and promotion, was first defined for skin carcinogenesis and forms the basis of the "two stage hypothesis" (Berenblum & Shubik, 1947; Salaman & Roe, 1964) .
Interest in recent years has been increasingly focused on the important problem of identifying factors that modify the "initiation and promotion" phases of carcinogenesis in various organs.
It is now clearly established that the number of tumours in skin or in liver is increased when the cells are stimulated to proliferate before the administration of the carcinogen, suggesting that rapidly proliferating cells are more susceptible to the initiating effect of a carcinogen (Glinos et al., 1951; Pound & Withers, 1963; Frei & Harsono, 1967; Hollander & Bentvelzen, 1968; Svoboda & Reddy, 1970; Craddock, 1971; Reddy et al., 1976a; Pound & McGuire, 1978a) . Furthermore, cell proliferation also appears to play an important part in the promotion of carcinogenesis, especially in skin (Boutwell, 1974; Frei, 1976; Yuspa et al., 1976; Slaga et al., 1976) . Peraino et al. (1971; reported that feeding a diet containing phenobarbital to rats previously fed the hepatocarcinogen, 2-aceylaminofluorene for a brief period, markedly increased the subsequent incidence of hepatic tumour, suggesting that the stages of initiation and promotion are also operable in liver tumorigenesis. Subsequent work by Weisburger et al. (1975) confirmed the tumour-promoting effect of phenobarbital in rat liver, though the mechanism of phenobarbital promotion remains unknown. Phenobarbital is a widely used drug which causes hepatomegaly, due to increased cell division and proliferation of smooth endoplasmic reticulum in liver cells, as well as inducing drugmetabolizing microsomal enzymes (Conney, 1967; Schulte-Hermann, 1974) . In recent years, an increasing array of natural and synthetic chemicals such as pesticides, drugs, food additives and other xenobiotics has been shown to induce hepatomegaly and enzyme induction similar to that due to phenobarbital treatment (Barka and Popper, 1967; ShulteHerman, 1974) . Since these agents are potential environmental contaminants, it would be important to assess their role as promoters of liver carcinogenesis, even if they are found to be non-carcinogenic.
We have shown that several hypolipidemic agents, when administered to rats and mice, produce a profound hepatomegalic effect associated with proliferation of peroxisomes in liver cells (Reddy et al., 1974; Reddy & Krishnakantha, 1975) . Since these agents are administered clinically for prolonged periods, for the control of hyperlipidemia, delineation of various long-term effects of persistent peroxisome proliferation and hepatomegaly appears necessary. Long-term treatment with one of these agents, nafenopin, a closely related analogue of the hypolipidemic drug clofibrate, caused the development of hepatocellular carcinomas in mice and rats (Reddy et al., 1976b; . We now report that Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2 -pyrimidinylthio] acetic acid), a potent hepatic peroxisome proliferator (Reddy & Krishnakantha, 1975) when administered to rats after a 14-day initiation with the carcinogen diethylnitrosamine, enhances the development of liver tumours in rats. A comparison has also been made with the promoting effects of clofibrate on liver tumorigenesis in rats similarly exposed to diethylnitrosamine. 
RESULTS
All rats survived the 14-day treatment with DEN in drinking water. Laparotomies performed at 22 weeks revealed the presence of one or more grossly visible nodules 2-6 mm in diameter in the livers of -,60% of rats fed Wy-14,643 after DEN initiation. In contrast, only an occasional rat fed clofibrate, and none of the rats on control diet, after DEN initiation, had grossly visible lesions at 22 weeks. Histological examination of the livers of rats killed at this time (2 animals from each group) showed hyperplastic nodules and many foci of liver-cell proliferation in only the Wy-14,643 group (Fig. 1) .
Between 38 and 48 weeks, 5/28 rats fed Wy-14,643 after DEN initiation, died with liver tumours. As these animals lost considerable weight, all surviving rats were killed at the 48th week and examined for hepatic tumours-. The Table compares the liver tumour incidence in the 3 groups. The data indicate that 5/18 rats (27%) fed control diet after DEN initiation developed liver tumours. A total of 7 tumours were found in these 5 livers, only 3 of which were 10-15 mm in diameter. In contrast, all 28 rats (100%) fed 0.1% Wy-14,643 after DEN initiation, devel- oped multiple liver tumours, 2-35 mm in diameter, involving all lobes (Fig. 2) . For convenience, the data in the showed liver tumours. The overall tumour incidence in the clofibrate group was significantly greater than that in the control group, but was significantly less than that in the Wy-14,643 group. In animals fed control diet after DEN initiation, only 3 hepatocellular carcinomas were found, but several livers contained an occasional microscopic focus of altered liver cells (Fig. 4) , suggesting tumour foci, that were either dormant or proliferating very slowly.
DISCUSSION
Of several factors that appear to promote the chemical carcinogen-initiated development of liver tumours (Glinos et al., 1951; Hollander & Bentvelzen, 1968; Svoboda & Reddy, 1970; Pound & McGuire, 1978a and b; Feinstein et al., 1978) , phenobarbital (Peraino et al., 1971 ) and dichlorodiphenyltrichloroethane (DDT) (Peraino et al., 1975) appear unique in that they produce hepatomegaly and stimulate DNA synthesis without causing liver-cell necrosis. Furthermore, both phenobarbital and DDT are potent inducers of smooth endoplasmic reticulum proliferation in liver cells, which is accompanied by an increase in liver microsomal enzymes (Conney, 1967; Schulte-Hermann, 1974) .
The results of the present study demonstrate that prolonged dietary administration of 2 hepatic peroxisome proliferators, Wy-14,643 and clofibrate, significantly enhance the development of liver tumours in rats previously exposed to DEN for a brief period. In addition to enhanced incidence, the number of hepatocellular tumours that developed in each rat, (Hess et al., 1965; Svoboda et al., 1967; Reddy & Krishnakantha, 1975) . In addition, they induce the proliferation of peroxisomes in liver cells, with an increase in some enzymes associated with this organelle (Reddy & Krishnakantha, 1975; Moody & Reddy, 1978) . These changes are considered analogous to the proliferation of smooth endoplasmic reticulum and induction of microsomal enzymes in liver by phenobarbital and other xenobiotics. Because of the long-term administration of drugs such as these for the control of hyperlipidemic states in man, it is essential to investigate various aspects of persistent hepatomegaly and peroxisome proliferation.
The mechanism of enhancement of liver tumorigenesis in animals fed Wy-14,643 or clofibrate, after DEN initiation remains to be elucidated. All potent peroxisome proliferators such as Wy-14,643, BR-931 and nafenopin (Reddy et al., 1978b; Moody et al., 1977) stimulate liver-cell proliferation during the initial stages of feeding, as well as causing cellular hypertrophy. The hepatomegalic as well as mitogenic effects of clofibrate appear somewhat less pronounced than with Wy-14,643 (Moody & Reddy, 1978) . The question arises whether the increased hepatocellular tumour yield in Wy-14,643-fed rats, over the clofibrate-fed group, reflects the mitogenic potency of this agent. Several studies have stressed that cell proliferation is important in the promotion of skin carcinogenesis (Boutwell, 1974; Frei, 1976) and it is possible that phenobarbital (Peraino et al., 1971 ) DDT (Peraino et al., 1975) carbon tetrachloride (Pound & McGuire, 1978b) and now the peroxisome proliferators, exert their enhancing effect on liver tumorigenesis by increasing the rate of liver-cell proliferation. In addition, drugs such as phenobarbital, DDT, Wy-14,643 and clofibrate increase the membranes in liver cells, and may influence membrane functions. The role, if any, of persistent increase in peroxisomes and/or smooth endoplasmic reticulum in liver-tumour promotion needs to be clarified. Furthermore, emerging evidence indicates that potent peroxisomes proliferators such as nafenopin, a closely related analogue of clofibrate, and Wy-14,643, which is structurally unrelated to clofibrate, are hepatocarcinogenic to rats and mice when administered for prolonged periods (Reddy et al., 1976b; Reddy et al., 1978a; Reddy, unpublished) . Unpublished data also suggest that the drug clofibrate may be a weak hepatocarcinogen. These observations, coupled with the data presented in this paper on the enhancing effect of Wy-14,643 and clofibrate on liver-tumour development in rats after DEN initiation, suggest the need for long-term studies with other hypolipidemic peroxisome proliferators to clarify the role of peroxisomes in hepatocarcinogenesis and/or in its promotion.
